Inventor
Mary E. Gerritsen
Inventor
San Mateo, CA, US
Overview
Patents· 49 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides19%
A61KPreparations for medical, dental or toiletry purposes17%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12NMicroorganisms or enzymes13%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture11%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C07HSugars6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
9,572,811'Treatment of dry eye'20179,452,156'Formulations and methods for vascular permeability-related diseases or conditions'20168,486,960'Formulations and methods for vascular permeability-related diseases or conditions'20138,222,271'Formulations and methods for vascular permeability-related diseases or conditions'20127,777,007'PRO9907 antibodies'20107,704,498'ErbB4 antagonists'20107,700,736'PRO350 antibodies'20107,582,293'Anti-PRO6308 antibodies'20097,572,447'Methods and compositions for selective modulation of vascularization'20097,557,192'Anti-PRO335 antibodies'20097,504,480'PRO10275 polypeptides'20097,470,771'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20087,456,261'PRO9830 antibodies'20087,432,345'PRO1475 polypeptide'20087,429,641'PRO9830 polypeptides'20087,417,116'PRO7155 polypeptides'20087,407,660'Methods and compositions for selective modulation of vascularization'20087,408,042'Anti-PRO6181 antibodies'20087,390,879'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20087,385,031'PRO6097 polypeptides'20087,332,579'Antibodies to human ErbB4'20087,317,092'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20087,309,778'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20077,294,693'Pro4428 Polypeptides'20077,288,384'Antibodies to polypeptides encoded by a nucleic acid underexpressed in esophageal tumor'20077,285,644'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20077,279,552'Pro1782 polypeptides'20077,230,082'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20077,208,308'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20077,196,165'PRO363 polypeptides'20077,189,563'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20077,189,813'PRO1338 polypeptides'20077,189,529'PRO792 nucleic acids'20077,160,993'Nucleic acids encoding PRO4400 polypeptides'20077,135,334'PRO20044 nucleic acids'20067,109,305'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20067,094,567'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20067,081,520'Anti-pro 1570 antibodies'20067,074,592'Secreted and transmembrane polypeptides nucleic acid encoding'20067,070,955'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20067,056,736'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20067,029,874'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20067,018,837'Nucleic acids encoding secreted polypeptides that stimulate release of proteoglycans from cartilage'20066,974,689'Nucleic acid encoding PRO211 polypeptides'20056,936,254'Method of inducing fetal hemoglobin synthesis'20056,858,427'Sphingosine kinases'20056,723,535'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20046,664,376'Secreted and transmembrane polypeptides and nucleic acids encoding the same'20036,635,468'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2010Patents assigned to GENENTECH INC (45)· patent assignee history
2003–2017Based in San Mateo, CA, US· patent location history
2012–2016Patents assigned to SANTEN PHARMACEUTICAL CO LTD (3)· patent assignee history
2012–2013Patents assigned to GERRITSEN MARY E (2)· patent assignee history
2012–2013Patents assigned to KLEINMAN DAVID M (2)· patent assignee history
2012–2013Patents assigned to NIVAGGIOLI THIERRY (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 45 | 2003–2010 |
| SANTEN PHARMACEUTICAL CO LTD | 3 | 2012–2016 |
| GERRITSEN MARY Eself | 2 | 2012–2013 |
| KLEINMAN DAVID M | 2 | 2012–2013 |
| NIVAGGIOLI THIERRY | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Mateo, California, US | 49 | 2003–2017 |